Skip to main content

Featured

Budget 2026 Consultations Are Open — Here's What Canadians Should Ask For

July 7, 2026 Ottawa wants your input on Budget 2026 before September 8. Here's what the consultation actually is, why it matters to your wallet, and what to say if you take part. The bottom line: On July 6, Finance Minister François-Philippe Champagne launched pre-budget consultations for this fall's federal budget. Canadians can submit input online until September 8, 2026 at Canada.ca/yourbudget. It's a rare, direct window to flag what's actually squeezing your household before the government finalizes tax, benefit, and spending decisions for next year. What Just Happened The Department of Finance officially opened the pre-budget consultation process for Budget 2026, which will be tabled this fall. The stated priorities are broad — boosting investment and competition, strengthening economic sovereignty, and addressing the "most pressing economic challenges facing Canadians today." Over the summer, Champagne, along with Secretary of State Wayne Long and Parl...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment